Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study.

by Lisanne L Krens, Lieke H J Simkens, Jara M Baas, Els R Koomen, Hans Gelderblom, Cornelis J A Punt, Henk-Jan Guchelaar
Published 2014-01-01

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.

by Sjoerd T Ligthart, Frank A W Coumans, Francois-Clement Bidard, Lieke H J Simkens, Cornelis J A Punt, Marco R de Groot, Gerhardt Attard, Johann S de Bono, Jean-Yves Pierga, Leon W M M Terstappen
Published 2013-01-01

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

by Sophie A. Kurk, Petra H. M. Peeters, Bram Dorresteijn, Pim A. deJong, Marion Jourdan, Geert‐Jan M. Creemers, Frans L. G. Erdkamp, Felix E. deJongh, Peter A. M. Kint, Boelo J. Poppema, Sandra A. Radema, Lieke H. J. Simkens, Bea C. Tanis, Manuel L. R. Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis J. A. Punt, Miriam Koopman, Anne M. May
Published 2020-02-01